ARRAYit, a life science technology company engaged in the development, manufacture and marketing of life science tools and integrated systems, has received from the University of California a $104,000 purchase order for the company’s life science instruments product line.
The University of California is one of the nation’s most prestigious educational and research systems comprising 442,000 students and employees scattered across 10 campuses, and has an investment portfolio of retirement, endowment and cash assets of $78.5 billion.
ARYC said it will book the recent sale to the University of California as revenue and earnings in the current quarter.
In addition to being installed at the University of California, ARYC’s microarray platform is currently installed in 4,000 research centers globally, as well as in numerous leading academic, government, biotech, pharmaceutical and diagnostic companies.
By providing analysis of genetic variation, biological function and diagnostics with inherent versatility, affordability and performance, ARYC is favored among researchers and empowers researchers to manufacture, scan and analyze microarrays prepared from cellular and synthetic DNA, RNA, proteins, peptides, carbohydrates, lipids, small molecules, tissues, whole cells and nanoparticles.
For more information visit www.arrayit.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment